11 Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: The NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank

12 Understanding cognitive and emotional illness representations of South Asian head and neck cancer survivors: a qualitative study.

13 Primary triple head and neck tumors: Laryngeal squamous cell carcinomas, Kaposi's sarcoma, and non-Hodgkin's lymphoma.

14 Primary triple head and neck tumors: Laryngeal squamous cell carcinomas, Kaposi's sarcoma, and non-Hodgkin's lymphoma

15 Synthesis and preclinical investigation of Tc-p-SCN-Bzl-DTPA-cetuximab for targeting EGFR using head and neck squamous cell carcinoma (HNSCC) xenografts.

16 LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.

17 Patterns of bone metastases from head and neck squamous cell carcinoma.

18 Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma

19 Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.

20 Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1.

21 Advances in Functional Imaging in the Assessment of Head and Neck Cancer.

22 E6 Oncoproteins from High-Risk Human Papillomavirus Induce Mitochondrial Metabolism in a Head and Neck Squamous Cell Carcinoma Model.

23 Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.

24 3D Rapid Prototyping for Otolaryngology-Head and Neck Surgery: Applications in Image-Guidance, Surgical Simulation and Patient-Specific Modeling.

25 Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.

26 Merkel cell carcinoma of the head and neck and associated second primary cancers: report of three cases.

27 Transcriptomic model-based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma.

28 Antibiotic Prophylaxis in Clean Head and Neck Surgery: An Observational Retrospective Single-Centre Study.

29 Do CO and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients.

30 Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.

31 The safety and benefit of using oxidized regenerated cellulose to position free flap pedicle in head and neck reconstruction.

32 High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.

33 Erratum: Safety standards for invasive procedures in out-patient departments, managing subglottic stenosis in pregnancy, a critical review on follow up of head and neck cancer patients, and a new classification for cochleovestibular malformations (Journal of Laryngology and Otology (2019) 133:5 (355-355) DOI: 10.1017/S0022215119001129)

34 Digitalization in Otorhinolaryngology: 90th Annual Meeting 2019 of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery, Berlin, May 29th–June 1st, 2019

35 Scientifically justified indication for nose septoplasty: Statement of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

36 Guideline “Implantable hearing aids”—short version: German S2k guideline of the Working Group of German-speaking Audiologists, Neurootologists and Otologists (ADANO), of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO) in collaboration with the German Society of Audiology (DGA), the German Society of Phoniatrics and Pediatric Audiology (DGPP), and patient representatives

37 Research Today—Future Tomorrow: 89th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

38 Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet.

39 Dosimetric and Monte Carlo verification of jaws-only IMRT plans calculated by the Collapsed Cone Convolution algorithm for head and neck cancers.

40 CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.

41 Resources for dysphagia. Dietary adaptations in head and neck cancer

42 Pacientes afectos de neoplasia de cabeza-cuello con nutrición enteral domiciliaria por sonda Head and neck cancer patients included at home enteral nutrition by tube

43 A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer

44 The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy forhead and neck squamous cell carcinoma (International Journal of Nanomedicine, 2019, 14, (623-638), 10.2147/IJN.S191069)

45 Patients' Perspectives on What Makes a Better Care Experience While Undergoing Treatment for Oropharyngeal Dysphagia Secondary to Head and Neck Cancer.

46 Usability study of the EduMod eLearning Program for contouring nodal stations of the head and neck

47 Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial.

48 Clinical Study of Extrapulmonary Head and Neck Tuberculosis: A Single-Institute 10-year Experience

49 Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial

50 Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.

51 Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects.

52 MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability

53 Outcomes for elderly patients 75 years and older treated with curative intent radiotherapy for mucosal squamous cell carcinomas of the head and neck

54 External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma.

55 CXCL11-CXCR3 axis mediates tumor lymphatic crosstalk and inflammation induced tumor promoting pathways in head and neck cancers.

56 Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy.

57 Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment.

58 Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.

59 Quality of life of head and neck cancer patients in urban and regional areas: An Australian perspective

60 Quality of life of patients from rural and urban areas in Poland with head and neck cancer treated with radiotherapy. A study of the influence of selected socio-demographic factors

61 Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer.

62 TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

63 NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy

64 Global frequency and distribution of head and neck cancer in pediatrics, a systematic review.

65 Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.

66 Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.

67 A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.

68 Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.

69 Does multiparametric imaging with F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?

70 CD8+CD73+ T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue.

71 Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic

72 Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.

73 HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification

74 Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations

75 Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer

76 Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

77 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

78 Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

79 Quality of life of head and neck cancer patients before and after cancer-directed treatment – A longitudinal study

80 Microvascular soft tissue reconstruction in the head and neck

81 Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer

82 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

83 Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study

84 Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations

85 Management of animal and human bites in the head and neck

86 Management of Animal and Human Bites in the Head and Neck

87 Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study

88 Machine Learning Applications for Head and Neck Imaging.

89 evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy

90 involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma.

91 pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy

92 profiling the behavior of distinct populations of head and neck cancer stem cells

93 recent advances in chemotherapy for head and neck cancers

94 novel immunotherapeutic approaches for head and neck squamous cell carcinoma

95 low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer

96 radiation-induced caries as the late effect of radiation therapy in the head and neck region

97 survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis

98 second primary cancer in patients with head and neck squamous cell carcinoma: case report

99 multimodality imaging of paragangliomas of the head and neck

100 diagnostic value of the upper lip bite test in predicting difficulty in intubation with head and neck landmarks obtained from lateral neck x-ray

101 A Pilot Longitudinal Study of 3-Dimensional Head and Neck Kinematics During Functional Tasks in Individuals With Chronic Idiopathic Neck Pain Either Wait-Listed for or Receiving Chiropractic Spinal Manipulative Therapy With Exercise.

Keyword Connections

Journals

Research Groups

Bibliographies